Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 25, 2024

Progress of circulating tumor DNA in the clinical management of colorectal cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

ZJZiwei JiangWFWei Fu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jiang et al. (2024) studied this question.

synapsesocial.com/papers/68e72771b6db6435876a1699https://doi.org/10.3760/cma.j.cn441530-20230203-00025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating tumour DNA in colorectal cancer: current and emerging clinical applications2026
  2. 2Circulating Tumor DNA as a Biomarker in Colorectal Cancer: Diagnostic, Prognostic, and Therapeutic Perspectives2025
  3. 3Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations2024 · 11 citations
  4. 4Circulating Tumor DNA-Based Assessment of Minimal Residual Disease in Colorectal Cancer: Prognostic and Predictive Implications2026 · 3 citations
  5. 5Circulating tumor DNA in gastrointestinal cancers: promise, pitfalls, and the path forward2026